These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7893882)

  • 1. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis.
    Wyrick PB; Davis CH; Raulston JE; Knight ST; Choong J
    Clin Infect Dis; 1994 Nov; 19(5):931-6. PubMed ID: 7893882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin.
    Wyrick PB; Knight ST
    J Antimicrob Chemother; 2004 Jul; 54(1):79-85. PubMed ID: 15163653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of azithromycin on Chlamydia trachomatis infected, polarized human endometrial epithelial cells.
    Wyrick PB; Davis CH; Knight ST; Choong J
    J Antimicrob Chemother; 1993 Jan; 31(1):139-50. PubMed ID: 8383102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.
    Dreses-Werringloer U; Padubrin I; Zeidler H; Köhler L
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3001-8. PubMed ID: 11600348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Resistance Screening in Chlamydia trachomatis by Optimized McCoy Cell Culture System and Direct qPCR-Based Monitoring of Chlamydial Growth.
    Meštrović T; Virok DP; Ljubin-Sternak S; Raffai T; Burián K; Vraneš J
    Methods Mol Biol; 2019; 2042():33-43. PubMed ID: 31385269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis.
    Reveneau N; Crane DD; Fischer E; Caldwell HD
    Antimicrob Agents Chemother; 2005 May; 49(5):1787-93. PubMed ID: 15855497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
    Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
    J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
    Zheng H; Xue Y; Bai S; Qin X; Lu P; Yang B
    Sex Transm Dis; 2015 Mar; 42(3):115-9. PubMed ID: 25668641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections.
    Mishra MK; Kotta K; Hali M; Wykes S; Gerard HC; Hudson AP; Whittum-Hudson JA; Kannan RM
    Nanomedicine; 2011 Dec; 7(6):935-44. PubMed ID: 21658474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    Pitt R; Alexander S; Ison C; Horner P; Hathorn E; Goold P; Woodford N; Cole MJ
    J Antimicrob Chemother; 2018 Mar; 73(3):680-686. PubMed ID: 29207004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of azithromycin to Chlamydia trachomatis-infected polarized human endometrial epithelial cells by polymorphonuclear leucocytes.
    Paul TR; Knight ST; Raulston JE; Wyrick PB
    J Antimicrob Chemother; 1997 May; 39(5):623-30. PubMed ID: 9184362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.
    Srivastava P; Bhengraj AR; Jha HC; Vardhan H; Jha R; Singh LC; Salhan S; Mittal A
    DNA Cell Biol; 2012 Mar; 31(3):392-401. PubMed ID: 21848430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection.
    Renault CA; Israelski DM; Levy V; Fujikawa BK; Kellogg TA; Klausner JD
    Sex Health; 2011 Mar; 8(1):69-73. PubMed ID: 21371385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis.
    Deguchi T; Hatazaki K; Ito S; Kondo H; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M
    J Infect Chemother; 2018 Aug; 24(8):610-614. PubMed ID: 29627327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.
    Manavi K; Hettiarachchi N; Hodson J
    Int J STD AIDS; 2016 Dec; 27(14):1303-1308. PubMed ID: 26511655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials.
    Shima K; Kaufhold I; Eder T; Käding N; Schmidt N; Ogunsulire IM; Deenen R; Köhrer K; Friedrich D; Isay SE; Grebien F; Klinger M; Richer BC; Günther UL; Deepe GS; Rattei T; Rupp J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cohort study of Chlamydia trachomatis treatment failure in women: a study protocol.
    Hocking JS; Vodstrcil LA; Huston WM; Timms P; Chen MY; Worthington K; McIver R; Tabrizi SN;
    BMC Infect Dis; 2013 Aug; 13():379. PubMed ID: 23957327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Chlamydial infections: 2014 update.
    Kohlhoff SA; Hammerschlag MR
    Expert Opin Pharmacother; 2015 Feb; 16(2):205-12. PubMed ID: 25579069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin in the management of Chlamydia trachomatis infections.
    Ridgway GL
    Int J STD AIDS; 1996; 7 Suppl 1():5-8. PubMed ID: 8652727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.